1. OAR@UM
  2. Faculty of Medicine and Surgery
  3. Department of Pathology
  4. Scholarly Works - FacM&SPat
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/108906
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrech, Godfrey-
dc.contributor.authorScerri, Christian-
dc.contributor.authorSaliba, Christian-
dc.contributor.authorBaldacchino, Shawn-
dc.date.accessioned2023-04-26T07:34:46Z-
dc.date.available2023-04-26T07:34:46Z-
dc.date.issued2018-
dc.identifier.citationGrech, A, Scerri, C., Saliba, C., & Baldacchino, S. (2018). Biomarkers predicting sensitivity to PP2A activation therapy in cancer. International application published under the Patent Cooperation Treaty (PCT-EP2018-057189). International Publication WO 2018/172419 Al.en_GB
dc.identifier.urihttps://patents.google.com/patent/WO2018172419A1/en?oq=PCT-EP2018-057189-
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/108906-
dc.description.abstractThe invention relates to the treatment and classification of cancer, in particular breast cancer. It relates to identifying patients who are likely to respond to cancer therapy with a PP2 A activator. Background: The provision of new treatments for cancer is of high importance, including for cancers resistant to known treatments. There is also a need for identification of markers that allow for detection, prognosis and classification of cancer, and which can predict responsiveness of a patient to a given therapy. The deregulation of the protein phosphatase 2A (PP2A) complex is known to be a common event in cancer [Grech et al; Tumor Biol; DOl 10.1007/s13277-016-5145-4 (2016)].en_GB
dc.language.isoenen_GB
dc.publisherPatent Cooperation Treaty (PCT)en_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectBreast -- Cancer -- Classificationen_GB
dc.subjectBreast -- Cancer -- Treatmenten_GB
dc.subjectPhosphoprotein phosphatases -- Inhibitorsen_GB
dc.subjectProtein phosphatase 2en_GB
dc.subjectBiochemical markers -- Diagnostic useen_GB
dc.titleBiomarkers predicting sensitivity to PP2A activation therapy in canceren_GB
dc.typepatenten_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
Appears in Collections:Scholarly Works - FacM&SPat

Files in This Item:
File Description SizeFormat 
Patent_WO2018172419A1.pdf901.76 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.